Protecting Kids from Pneumonia La Plata MD

The current recommended dose schedule for 7-valent pneumococcal conjugate vaccine (PCV-7) consists of three primary doses before the age of 6 months, followed by a booster vaccination in the second year of life (3 + 1-dose schedule) in La Plata.

AMIR Mirza-Alikhani Board Physician
(301) 934-6068
101 Centennial Street
La Plata, MD
 
Family Health Care Physicians PA
(301) 870-3118
605 Charles Street
La Plata, MD
 
Shah Minaxi MD
(301) 870-3118
605 Charles Street
La Plata, MD
 
Gabriel O Obiadi
(301) 609-4000
701 Charles St
La Plata, MD
Specialty
Pediatrics

Data Provided by:
Dr. Jean Ann Schoonover
(301) 609-3160
404 E Charles St
La Plata, MD
Specialty
Pediatrics

Solomon Valerie MD
(301) 870-3118
605 Charles Street
La Plata, MD
 
Osei Henry K MD
(301) 870-3118
605 Charles Street
La Plata, MD
 
Finizio Joseph P MD
(301) 870-8434
Pembrooke Square
La Plata, MD
 
Wubshet Berhane MD
(301) 870-3118
605 Charles Street
La Plata, MD
 
Ilevba Uwaila Osarenkhoe
(301) 609-4094
701 Charles St
La Plata, MD
Specialty
Pediatrics

Data Provided by:
Data Provided by:

Protecting Kids from Pneumonia

Provided By:

Parents and babies alike will be relieved by new findings that show a reduced-dose schedule for the pneumococcal vaccine can protect infants against pneumonia and other infections.

The current recommended dose schedule for 7-valent pneumococcal conjugate vaccine (PCV-7) consists of three primary doses before the age of 6 months, followed by a booster vaccination in the second year of life (3 + 1-dose schedule). But factors such as questions about the cost-effectiveness of the current PCV-7 dose schedule have led researchers to examine reduced-dose vaccine schedules, according to background information in the study.

The researchers, Dr. Elske J.M. van Gils, of the University Medical Center Utrecht in the Netherlands, and colleagues, studied 1,003 healthy infants who were randomly assigned to receive two doses of PCV-7 at 2 months and 4 months of age, or a 2 + 1-dose schedule at 2, 4 and 11 months of age, or no vaccine (control group). The children were checked after 12 months, 18 months and 24 months for pneumococcal microorganisms in the upper part of the throat behind the nose.

Compared to those in the control group, children in both vaccine groups had far lower rates of microorganisms that can cause pneumonia and other infections, according to the report in the July 8 issue of the Journal of the American Medical Association.

"In conclusion, both two-dose and 2 + 1-dose schedules of PCV-7 significantly reduce vaccine serotype pneumococcal carriage in children. This study supports future implementation of reduced-dose PCV-7 schedules," the researchers concluded.

More information

The Nemours Foundation has more about children and pneumonia.

SOURCE: Journal of the American Medical Association, news release, July 7, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com